Bio-Techne Corp (TECH) Stock Analysis

Bio-Techne Corp (TECH) is a publicly traded company in the HEALTHCARE sector. It trades at $49.77, carries a market capitalization of $7.95B, a price-to-earnings ratio of 72.56. This page summarizes the public market data, fundamentals, and frequently asked questions for TECH, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Bio-Techne Corp currently has a Bullish sentiment score of 0.20.

About Bio-Techne Corp

Bio-Techne Corporation (Ticker: TECH) is a premier global provider of high-quality life science reagents, instruments, and services, with a strong focus on clinical diagnostics and research applications. Based in Minneapolis, Minnesota, the company utilizes cutting-edge technologies to drive innovation across key areas such as genomics, proteomics, and cellular analysis. Bio-Techne supports a wide range of clients, including academic institutions, pharmaceutical companies, and clinical labora...

GNG Research Analysis

GNG Research scores Bio-Techne Corp (TECH) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for TECH.

Frequently Asked Questions

Does TECH pay dividends?

Bio-Techne Corp (TECH) does not currently pay a regular dividend.

What is TECH's P/E ratio?

Bio-Techne Corp has a price-to-earnings (P/E) ratio of 72.56.

What is TECH's market cap?

Bio-Techne Corp (TECH) has a market capitalization of $7.95B with a current stock price of $49.77.